Skip to content

Clinical trials

Insulin Resistance trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Insulin Resistance Country / region: Japan Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20061
20071
20081
20094
20102
20112
20145
20181
20191
20201
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Unknown status3
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tanabe Pharma Corporation10
Sanwa Kagaku Kenkyusho Co., Ltd.3
Eli Lilly and Company2
Kobe University2
Tottori University Hospital2
Astellas Pharma Inc1
Nagoya University1
Osaka Metropolitan University1
Prof. Valérie Mc Lin1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Insulin Resistance26
Diabetes Mellitus, Type 217
Diabetes Mellitus5
Metabolic Syndrome4
Hypertension3
Diabetes Mellitus, Lipoatrophic2
Hyperglycemia2
Hyperlipidemias2
Hyperuricemia2
Hypoglycemia2

Trials

Showing 26 to 26 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.